New

Sr. Mgr/Associate Director, Forecasting

Kura Oncology
401(k), stock options
United States, Massachusetts, Boston
2 Seaport Lane (Show on map)
Feb 01, 2025
Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions. ESSENTIAL JOB FUNCTIONS: The Sr. Mgr/Associate Director of Forecasting role will play a critical role in developing our launch forecast for ziftomenib in relapsed / refractory acute myeloid leukemia (AML) as well as long-term forecasts for lifecycle indications across the portfolio. This individual will report to the Sr. Director of Commercial Insights and Analytics and will be responsible for building and maintaining revenue forecasts, and for coordinating forecast workstreams in partnership with cross-functional stakeholders including Marketing, Finance, Market Access and Manufacturing. The successful candidate will have deep technical forecasting expertise and strong strategic thinking, combined with effective communication skills. Develop, implement and update patient-based forecasts and lead forecasting business processes, including quarterly LEs, annual LRF, and annual strategic plan Guide the analytics and insights necessary to inform and support forecast assumptions, and integrate emerging data and insights into regular forecast updates Identify uncertainties and conduct sensitivity and scenario modeling to inform understanding of risks and opportunities Be a strategic thought partner to the business by providing actional insights & recommendations based on forecasting results to support strategic planning and decision-making Collaborate with cross-functional partners, including marketing, sales, finance and manufacturing, to ensure alignment of forecast assumptions with business strategies and objectives Partner with analytics and insights team members to ensure consistency and alignment between forecasting and performance tracking workstreams Develop and communicate forecasting presentations, including assumptions, rationale, and supporting information across a range of stakeholders, including senior leadership and co-promotion partners Conduct opportunity assessments and support business case development to inform pipeline investments and portfolio prioritization Ensure objectivity of product forecasts, and manage and refine forecasting models to improve accuracy and reliability over time JOB SPECIFICATIONS: Minimum of a Bachelor of Science degree in business management, finance, statistics, or a related field. MBA / advanced degree preferred. 5+ years of experience in commercial pharmaceutical forecasting, or relevant experience in a consulting firm. Excellent financial modeling and long-term/short-term forecasting skills, including deep experience in building and maintaining patient flow models and applying methodologies for sensitivity modelling/monte carlo simulations etc Strong understanding and experience utilizing and integrating data and insights from primary market research, competitive intelligence, data analytics, and other standard secondary data sources Proven effectiveness in leading through ambiguity, with the ability to develop credible recommendations and strengthen confidence in forecast assumptions when available data is imperfect Experience managing a US oncology / hematology product forecast through launch, and across multiple lines of therapy and lifecycle indications Excellent communication, presentation and interpersonal skills, with demonstrated ability to influence laterally and vertically Demonstrated ability to story-tell using data and effectively communicate forecasting and technical ideas and results to senior leadership and non-technical stakeholders in written and verbal form Strong track record of effective collaboration and partnership with cross-functional teams to socialize relevant insights and takeaways and ensure alignment on forecast assumptions Demonstrated ability to balance attention to detail with the ability to understand and communicate the strategic implications of operational decisions and forecast assumptions The base range for an Associate Director is $174,740 - $203,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. Kura's Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays (Including Summer & Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts. Kura's pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website atwww.kuraoncology.comand follow us onXandLinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.